These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 28980935

  • 1. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
    Sadrin S, Sennoune SR, Gout B, Marque S, Moreau J, Grillasca J, Pons O, Maixent JM.
    Cell Mol Biol (Noisy-le-grand); 2017 Sep 30; 63(9):122-131. PubMed ID: 28980935
    [Abstract] [Full Text] [Related]

  • 2. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.
    Sadrin S, Sennoune S, Gout B, Marque S, Moreau J, Zinoune K, Grillasca JP, Pons O, Maixent JM.
    Dig Liver Dis; 2020 May 30; 52(5):534-540. PubMed ID: 31952938
    [Abstract] [Full Text] [Related]

  • 3. Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives.
    Maixent JM, Pons O, Sennoune SR, Sadrin S.
    Cell Mol Biol (Noisy-le-grand); 2020 Jun 05; 66(3):211-214. PubMed ID: 32538776
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 05; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 6. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
    Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L.
    World J Gastroenterol; 2016 Dec 28; 22(48):10631-10642. PubMed ID: 28082816
    [Abstract] [Full Text] [Related]

  • 7. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 28; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 8. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome.
    Pineton de Chambrun G, Neut C, Chau A, Cazaubiel M, Pelerin F, Justen P, Desreumaux P.
    Dig Liver Dis; 2015 Feb 28; 47(2):119-24. PubMed ID: 25488056
    [Abstract] [Full Text] [Related]

  • 9. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
    Ringel-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringel Y.
    J Clin Gastroenterol; 2011 Jul 28; 45(6):518-25. PubMed ID: 21436726
    [Abstract] [Full Text] [Related]

  • 10. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG.
    J Gastroenterol Hepatol; 2014 Jan 28; 29(1):52-9. PubMed ID: 23829297
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Oh JH, Jang YS, Kang D, Chang DK, Min YW.
    Nutrients; 2019 Nov 27; 11(12):. PubMed ID: 31783597
    [Abstract] [Full Text] [Related]

  • 12. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R, Casale C, Pistelli R, Rapaccini GL, de Vitis I.
    Eur Rev Med Pharmacol Sci; 2014 Nov 27; 18(9):1344-53. PubMed ID: 24867512
    [Abstract] [Full Text] [Related]

  • 13. [Probiotic supplement (Lactobacillus acidophilus and bulgaricus) utility in the treatment of irritable bowel syndrome].
    Diaz Ferrer J, Parra V, Bendaño T, Montes P, Solorzano P.
    Rev Gastroenterol Peru; 2012 Nov 27; 32(4):387-93. PubMed ID: 23307089
    [Abstract] [Full Text] [Related]

  • 14. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial.
    Bauserman M, Michail S.
    J Pediatr; 2005 Aug 27; 147(2):197-201. PubMed ID: 16126049
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled trial of probiotics after colonoscopy.
    D'Souza B, Slack T, Wong SW, Lam F, Muhlmann M, Koestenbauer J, Dark J, Newstead G.
    ANZ J Surg; 2017 Sep 27; 87(9):E65-E69. PubMed ID: 26183594
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome.
    Sinn DH, Song JH, Kim HJ, Lee JH, Son HJ, Chang DK, Kim YH, Kim JJ, Rhee JC, Rhee PL.
    Dig Dis Sci; 2008 Oct 27; 53(10):2714-8. PubMed ID: 18274900
    [Abstract] [Full Text] [Related]

  • 17. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.
    Yoon JY, Cha JM, Oh JK, Tan PL, Kim SH, Kwak MS, Jeon JW, Shin HP.
    Dig Dis Sci; 2018 Oct 27; 63(10):2754-2764. PubMed ID: 29876777
    [Abstract] [Full Text] [Related]

  • 18. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):387-94. PubMed ID: 16128676
    [Abstract] [Full Text] [Related]

  • 19. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
    Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE.
    Scand J Gastroenterol; 2013 Oct 01; 48(10):1127-35. PubMed ID: 23957590
    [Abstract] [Full Text] [Related]

  • 20. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.
    Ducrotté P, Sawant P, Jayanthi V.
    World J Gastroenterol; 2012 Aug 14; 18(30):4012-8. PubMed ID: 22912552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.